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OBJECTIVES The purpose of this study was to analyze cardiac tissue and blood for viral genomes using
polymerase chain reaction (PCR) to define the common viral etiologies of myocarditis by age
group.
BACKGROUND Enteroviruses are considered the most common cause of myocarditis at all ages. Diagnosis
relies on viral cultures, serology, and cardiac histology, which lack sensitivity, as well as PCR.
However, in many cases enteroviruses are not detected.
METHODS Cardiac samples were obtained for PCR analysis from patients with myocarditis (n  624)
and dilated cardiomyopathy (DCM) (n  149). Patients were analyzed by age group,
including neonates (n  116), infants (n  191), toddlers (n  87), children (n  110),
adolescents (n  92), and adults (n  177). After nucleic acids had been extracted from an
endomyocardial biopsy, an explant, or autopsy samples, PCR and reverse transcription PCR
were performed to detect the genomic sequences of enterovirus, adenovirus, cytomegalovirus
(CMV), herpes simplex virus (HSV), Epstein-Barr virus (EBV), parvovirus, respiratory
syncytial virus (RSV), and influenza A virus.
RESULTS Viral genome was amplified (adenovirus  142, enterovirus  85, CMV  18, parvovirus 
6, influenza A 5, HSV 5, EBV 3, RSV 1) from 239 (38%) of the 624 samples from
myocarditis patients, including 26 patient samples in which dual infection was found. Virus
was detected in 30 (20%) of 149 DCM patient samples; only adenovirus (n  18) and
enterovirus (n  12) were detected.
CONCLUSIONS Polymerase chain reaction identified adenovirus as the most common virus in the myocardium
of children and adults with myocarditis and DCM. Although enteroviruses are also found in
these patients, they appear to be a less common cause of myocarditis than adenovirus. (J Am
Coll Cardiol 2003;42:466–72) © 2003 by the American College of Cardiology Foundation
Viral infections of the heart are important causes of mor-
bidity and mortality in children and adults. Acute myocar-
ditis typically presents with severe clinical manifestations,
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especially in the newborn period (1). Idiopathic dilated
cardiomyopathy (DCM) appears to occur as a late sequela of
acute or chronic viral myocarditis (2,3), either due to
persistence of virus (4) or to an autoimmune phenomenon
occurring secondary to previous exposure to the inciting
virus (5). The affected individual may require long-term
medical therapy for congestive heart failure (CHF) and, in
many cases, orthotopic heart transplantation (OHT). In
some cases, sudden cardiac death occurs (6), particularly in
athletes (7).
Enteroviruses, and especially the Coxsackievirus B family,
have been considered the most common cause of acute
myocarditis. Viral diagnosis has classically been based on
identification of virus by peripheral culture methods and/or
serial serology (2,8); isolation of virus from myocardium is
usually unsuccessful, however. Endomyocardial biopsy
(EMB) and histopathologic assessment were developed to
improve diagnostic capabilities, but they were inconsistent
among pathologists. It was hoped that the “Dallas” criteria
(9) would improve the high rate of diagnostic disagreement
by establishing uniform criteria. However, because of insen-
sitivity (10) and possible risks involved in biopsies, particu-
larly in small or critically ill children, many centers aban-
doned EMB as a diagnostic tool.
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The ability to diagnose viral infection in the cardiac tissue
of patients with myocarditis and DCM improved with the
advent of molecular hybridization by Bowles et al. (4,11).
These studies also led to the hypothesis that DCM was
caused by enteroviral persistence and supported the view
that DCM is a late sequela of viral myocarditis. More
recently, polymerase chain reaction (PCR) has been em-
ployed in the rapid detection of viral sequences in many
tissues and body fluids, including Coxsackievirus-specific
ribonucleic acid (RNA) in the myocardium of patients with
suspected myocarditis or DCM (12–15). Evidence from our
laboratory suggested that adenovirus is a commonly associ-
ated viral genome found in hearts of affected children and
could be an important cause of myocarditis and DCM
(16–18). The purpose of this study was to analyze the
etiologic agents potentially responsible for myocarditis and
DCM in different age groups.
METHODS
Clinical diagnostic criteria. Inclusion criteria for the study
included initial presenting symptoms of acute cardiovascular
collapse, acute CHF with or without ventricular tachycar-
dia, and evidence of cardiac dysfunction using noninvasive
methods.
Echocardiographic criteria used in the diagnosis of acute
myocarditis or chronic cardiomyopathy included left ven-
tricular (LV) dysfunction and ventricular dilation calculated
from M-mode echocardiograms (19). Doppler and color
Doppler were used to determine atrioventricular valve re-
gurgitation.
After cardiac catheterization and EMB, up to nine biopsy
specimens (1.8 mm3 or 2.2 mm3) were fixed in formalin for
histology, glutaraldehyde for electron microscopy, and cold
viral media for culture, with one or two samples either
snap-frozen in liquid nitrogen or formalin-fixed for PCR
analysis. All explanted hearts were sampled (right ventricle
[RV] and LV) and snap-frozen within 10 min of explanta-
tion. All autopsies were performed in standard fashion; LV
and RV wedges were frozen, formalin-fixed, or paraffin-
embedded. All histologic results were based on the “Dallas”
criteria (9). The presumptive diagnosis of myocarditis was
based on histopathologic criteria of definite or borderline
myocarditis on biopsy using the “Dallas” criteria or a clinical
diagnosis of acute-onset heart failure (new-onset dyspnea
with associated hepatosplenomegaly, physical exam findings
of reduced cardiac output and gallop rhythm, and evidence
of DCM on chest X-ray or echocardiography) with history
of recent viral illness. In cases where chronic myopathic
changes were identified on histology, the diagnosis of DCM
was favored in the absence of significant inflammation. All
studies on humans were performed in accordance with local
institutional review board regulations.
Exclusion criteria. All children with the diagnosis of
anomalous left coronary artery from the pulmonary artery,
Kawasaki disease, adriamycin-induced cardiomyopathy,
critical neonatal aortic stenosis, or postoperative congenital
heart disease repair were excluded. Adults with evidence of
alcohol-induced cardiomyopathy, peripartum cardiomyopa-
thy, adriamycin-induced cardiomyopathy, or ischemic car-
diomyopathy were also excluded. All patients previously
published were excluded from this study.
Patient samples. Myocardial samples from 773 patients
with myocarditis and DCM enrolled in 20 institutions in
the U.S. were studied. All local patients (Texas Children’s
Hospital) were obtained consecutively, but samples from
other centers were selected on the basis of the clinical
judgment of the cardiologist. Sample sources included 357
RV EMB, 234 autopsy, and 182 specimens from explanted
hearts. Myocardial samples were collected from 165 age-
matched children and 50 adults undergoing OHT (n 
109) or autopsy (n  106). None of the patients evaluated
in this study has previously been published.
Evaluation for infection. Blood (n  301 samples), naso-
pharyngeal (n  189), urine (n  114), and stool (n  82)
samples were obtained when possible and cultured for virus
(total patients cultured  333). Serial serology for virus was
obtained when possible (n 452). Endomyocardial biopsies
were cultured for virus (n  96) and also evaluated for viral
particles by electron microscopy (n  206). Post-mortem
cardiac cultures were performed in 109 patients. Viral
cultures were performed using standard virologic tech-
niques, as previously described (16,17).
Template preparation and PCR. Total RNA and de-
oxyribonucleic acid were isolated simultaneously from fro-
zen, formalin-fixed tissue (1.8 to 3.0 mm3) or from paraffin-
embedded tissue sections, using a modification of the
RNAzol method, as previously described (16–18). Paraffin-
embedded tissue was first extracted with xylene (two times)
then washed in ethanol to remove the paraffin before
homogenization in RNAzol. Nucleic acids isolated from
cultures or tissues infected with Adenovirus Type 5, Cox-
sackievirus B4, cytomegalovirus (CMV) strain AD169,
herpes simplex virus (HSV) Type 1, parvovirus B19,
Epstein-Barr virus (EBV), or influenza virus type A were
used as positive controls.
For the detection of the enteroviruses, respiratory syncy-
tial virus (RSV), and influenza viruses (RNA viruses),
Abbreviations and Acronyms
CHF  congestive heart failure
CMV  cytomegalovirus
DCM  dilated cardiomyopathy
EBV  Epstein-Barr virus
EFE  endocardial fibroelastosis
EMB  endomyocardial biopsy
HSV  herpes simplex virus
LV  left ventricle/ventricular
OHT  orthotopic heart transplantation
PCR  polymerase chain reaction
RNA  ribonucleic acid
RSV  respiratory syncytial virus
RV  right ventricle/ventricular
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reverse transcriptase PCR was employed, whereas for ade-
novirus, CMV, HSV, parvovirus, and EBV (deoxyribonu-
cleic acid viruses), PCR was utilized (16–18).
All samples were analyzed without knowledge of the
clinical, culture, or serologic data and were performed in
duplicate. Verification of the presence of amplifiable nucleic
acid extracted from each sample was performed by ampli-
fication of cellular nucleic acid (K-ras or beta-actin).
Statistical analysis. We compared frequencies of virus
detection among myocarditis, DCM, and control groups by
chi-square analysis.
RESULTS
Patient population. Patients with a clinical picture or
hospital course consistent with the diagnosis of acute
myocarditis or DCM, presenting between January 1988 and
January 2000, in whom cardiac tissue and histology were
available, were analyzed. A total of 773 patients met this
initial inclusion criteria; ages ranged from one day to 42
years (mean age  6.2 years; median age  13 years). The
patients were divided into groups based on age: neonates
(age 1 day to 1 month, n  116), infants (age 1 month to
1 year, n  191), toddlers (age 1 year to 5 years, n  87),
children (age 5 years to 13 years, n  110), adolescents (age
13 years to 18 years, n 92), and adults (age above 18 years,
n  177). A total of 165 children and 50 adults with
medical histories inconsistent with these criteria were in-
cluded as unaffected, age-matched control patients (de-
scribed later).
Clinical presentation. Of 773 affected individuals evalu-
ated, myocarditis was diagnosed in 624 and DCM in the
remainder (n  149). Patients presented with acute cardio-
vascular collapse (n  247), new-onset CHF (n  381),
respiratory distress (n 83), or ventricular tachycardia (n
62). Only 44 of the 624 patients with myocarditis did not
have a history consistent with a preceding viral illness. In the
149 patients with DCM, 12 had histories indicative of viral
infection.
The 165 control patients included 123 individuals with
congenital heart disease, 42 individuals with hypertrophic
cardiomyopathy, and 50 trauma victims. None had a history
of recent viral illness or histologic evidence of myocarditis.
Prognosis. The overall prognosis of the 624 patients with
acute myocarditis studied was poor, with an overall mortal-
ity of 51% (318 of 624). In the 149 DCM patients, 61
underwent OHT; one of these patients expired two months
post transplantation from disseminated CMV infection, and
the autopsy specimen was analyzed by PCR. The majority
of patients with myocarditis (430 of 624) had poor recovery
of their cardiac function (including all 318 of the deaths),
whereas the remaining patients had either mild recovery
with persistence of depressed cardiac function (89 of 624),
complete recovery (93 of 624), undergone transplantation
(121 of 624), or remained critically ill awaiting OHT (3 of
624). None of the “control” patients had history of recent
viral illness or signs and symptoms of acute cardiomyopathy.
When analyzed by age group, differences in outcome were
notable between groups (Table 1), as described below: for
neonates, 78 of 116 (67%) deaths, 12 of 116 (10%) persis-
tently depressed functions, and 26 of 116 (23%) improved;
for infants, 108 of 191 (55%) deaths, 26 of 191 (12%)
persistently depressed function, and 65 of 191 (32%) im-
proved; for toddlers, 19 of 87 (22%) deaths, 28 of 87 (32%)
persistently depressed function, and 40 of 87 (46%) im-
proved; for children, 28 of 110 (25%) deaths, 15 of 110
(14%) persistent dysfunction, and 67 of 110 (61%) im-
proved; for adolescents, 18 of 92 (20%) deaths, 12 of 92
(13%) persistently depressed function, and 62 of 92 (67%)
improved; for adults, 67 of 177 (38%) deaths, 19 of 177
(11%) persistently depressed function, and 91 of 177 (51%)
improved.
Serology/cultures. Significant neutralizing titers were de-
tected in 152 of the 452 (38%) patients studied (46
enterovirus, 12 adenovirus, 42 CMV, 9 HSV, 3 EBV, 7
parvovirus, 14 influenza, 19 RSV) using acute and conva-
lescent titers. Virus was cultured from peripheral samples
from 107 of 333 patients (38 enterovirus, 23 adenovirus, 28
CMV, 8 HSV, 2 EBV, 8 influenza), whereas 7 (6%) of 109
patients had positive post-mortem viral cultures. Four of
these patients had post-mortem positive cultures for entero-
Table 1. Clinical Outcome: Correlation by Age
Age Diagnosis # Patients Death Transplant
Persistent
DCM Improved
Newborn Myocarditis 93 78 13 12 26
(n  116) DCM 23 3 4 12 4
Infants Myocarditis 152 108 16 26 65
(n  191) DCM 39 7 12 11 9
Toddlers Myocarditis 69 19 9 28 40
(n  87) DCM 18 3 4 5 6
Children Myocarditis 90 28 21 15 67
(n  110) DCM 20 3 6 6 5
Adolescents Myocarditis 76 18 16 12 62
(n  92) DCM 16 5 6 3 2
Adults Myocarditis 144 67 46 19 91
(n  177) DCM 33 4 19 2 8
DCM  dilated cardiomyopathy.
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virus from heart, brain, liver, and kidney, and three patients
grew adenovirus from the lungs and heart. Two patients
grew CMV from the heart and lungs (one in a patient who
grew enterovirus, one in a patient who grew adenovirus).
One other child had negative viral cultures, but was noted to
have adenoviral-like particles in the heart by electron
microscopy.
PCR analysis. MYOCARDITIS. Polymerase chain reaction
amplified viral genome in 239 of 624 (38%) samples
obtained from patients with myocarditis (Table 2). Among
the different types of samples tested, 38% of RV EMB, 25%
of explanted tissue, and 53% of autopsy samples were
positive. Of the 239 positive PCR samples, 142 were
positive for adenovirus (Fig. 1), 85 for enterovirus, 18 for
CMV, six for parvovirus, five for influenza A, five for HSV
Type 1, three for EBV, and one for RSV, including 26
samples that were positive for two viruses (6 with adenovirus
and CMV, 6 with enterovirus and CMV, and 14 with
adenovirus and enterovirus). Sequence analysis of adenovi-
rus amplimers identified adenovirus type 2 in about 80% and
type 5 in the remainder, except for type 6 in one sample.
Of 107 patients with positive peripheral cultures, 86
(80%) amplified viral genome by PCR with 76% agreement
in the results (66 of 86). Polymerase chain reaction analysis
of blood obtained from 300 patients at the same time that
tissue was obtained amplified virus in just three (CMV in 2,
enterovirus in 1). In all age groups, adenovirus was most
commonly detected, with enteroviruses second-most com-
mon (Fig. 2).
DILATED CARDIOMYOPATHY. In 149 patients with DCM
(63 RV EMB, 25 autopsy, 61 explants), 30 myocardial
samples (20%) were positive for viral genome (Table 2).
Eighteen (60%) of the PCR-positive samples were positive
for adenovirus, with the remainder enterovirus (Fig. 3).
None of the blood samples from these patients was PCR-
positive.
CONTROLS. Of the 215 “control” samples, just three (1.4%)
amplified virus: enterovirus from one and CMV from two
(Table 2).
Histopathology. In the 624 patients with a clinical diag-
nosis of myocarditis, histopathology was consistent with
acute myocarditis in 409 (66%), whereas the remaining 215
were considered borderline myocarditis and had a history of
recent viral illness. Whereas 67 (79%) of the 85 enterovirus-
positive cases had acute myocarditis by histology, only 57
(40%) of the 142 adenovirus-positive cases had similar
findings, indicating that adenovirus infection is significantly
associated with less inflammation than enterovirus infection
(p  0.01).
Histology in patients with DCM demonstrated border-




PCR PCR Amplimer (#)*








DCM 149 30 (20%) Adenovirus 18 (12%)
Enterovirus 12 (8%)
Total 773 269 (35%)
Controls 215 3 (1.4%) Enterovirus 1 (1%)
CMV 2 (1%)
*In 26 samples from myocarditis patients, two viruses were detected.
CMV cytomegalovirus; DCM dilated cardiomyopathy; EBV Epstein-Barr
virus; HSV  herpes simplex virus; PCR  polymerase chain reaction; RSV 
respiratory syncytial virus.
Figure 1. (Left) A nine-month-old (TT) presented with a one-day history of fever, irritability, poor feeding, respiratory distress, and poor ventricular
function by echocardiography. Death ensued within four hours of presenting to the emergency room. Formalin-fixed cardiac tissue (TTRV1) was positive
for adenovirus by polymerase chain reaction (PCR), as demonstrated by the 308 bp PCR product—the same size seen with the adenovirus type 5 control.
The 135 bp band is the k-ras PCR product. Note that Patient ALH’s right ventricular endomyocardial biopsy was negative for the adenoviral PCR product
but amplifies the 135 bp k-ras product. (Right) Southern blot and hybridization with a radiolabeled adenovirus probe.
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line or mild findings of inflammatory infiltrates in 16 of 149
cases (10%) in the face of chronic myopathy changes,
whereas the remaining 133 patients (90%) had histology
typical only of DCM. Significantly, in 11 (69%) of the 16
patients with inflammatory infiltrates, virus was detected,
compared with just 19 (14%) of the patients without
inflammation (p  0.01). Of the 11 DCM patients with
inflammatory infiltrates, nine were positive for enterovirus
and two were positive for adenovirus. Thus, there was a
statistically significant difference (p  0.01) between the
degree of inflammation in the enterovirus positive samples
(9 of 12  75%) compared with the adenovirus samples (2
of 18  11%).
DISCUSSION
Enteroviruses have been considered responsible for up to
50% of cases of acute myocarditis and for some cases of
DCM due to persistent viral infection (4,11–14,20). In this
report, we demonstrate adenoviruses to be significant causes
of myocarditis in both children and adults. However, this
should not be surprising. In 1958, Chany et al. (21) reported
23 patients with adenoviral pneumonia, eight ending in
fatality. Two of these children had associated myocarditis,
both due to adenovirus type 7a. Other reports of myocarditis
with adenoviral pneumonia have also been described (22).
Similarly, Henson and Mufson (23) reported an 11-month-
Figure 2. Number of myocarditis patients by age group, positive for viruses by polymerase chain reaction. CMV  cytomegalovirus; EBV  Epstein-Barr
virus; HSV  herpes simplex virus; RSV  respiratory syncytial virus.
Figure 3. Number of dilated cardiomyopathy patients by age group, positive for viruses by polymerase chain reaction. Black bars adenovirus; lined bars
enterovirus.
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old child with myocarditis and interstitial pneumonitis due
to adenovirus type 21. Gardiner and Short (24) studied 60
patients with acute myocarditis or pericarditis, finding
evidence of specific infection in only 18 patients, including
Coxsackievirus B in nine, adenovirus in two, and influenza
in two. Berkovich et al. (25) studied 12 children with
myocarditis; eight had laboratory evidence of recent viral
infection, and viral agents were isolated in five children. Of
these, two had adenovirus isolated from stool samples (types
1 and 2), whereas three children had enterovirus (Coxsack-
ievirus B2, B5, and Echovirus 11). In one child with
adenovirus, a pathologic diagnosis of endocardial fibroelas-
tosis (EFE) was made, possibly because of in utero myo-
carditis as a consequence of transplacental viral infection.
Recently, adenoviral myocarditis in fetuses with non-
immune hydrops was reported (26,27), supporting adeno-
virus as a possible cause of in utero heart disease. In
addition, studies in our laboratory (16,17,26,27) and others
(28) have shown adenoviral genome to be common within
the myocardium of children with myocarditis or DCM,
whereas Pauschinger et al. (18) found adenovirus and
enterovirus in adults with LV dysfunction.
In the study presented here, analysis of a large number of
samples identified adenoviral genome frequently in the
myocardium of patients with myocarditis of DCM (more
frequently than enteroviruses). However, because some of
the samples analyzed were formalin-fixed, it is possible that
the sensitivity of enteroviral RNA detection was reduced,
and a slightly lower rate of detection of the enteroviruses
was noted in fixed versus frozen samples, although this did
not reach statistical significance. Further, we have previously
reported studies of the detection of RNA viruses in fixed
tissue (17,29). None of the children (affected or controls)
was receiving immunosuppression and no difference in the
occurrence of routine infections was noted between controls
and affected children, supporting the cause-and-effect hy-
pothesis for the detection of viruses in the myocardium.
Interestingly, as we previously reported (16), histologic
analysis demonstrates that adenovirus-positive patients typ-
ically have mild or borderline myocarditis by the “Dallas”
criteria, whereas enteroviruses are more commonly associ-
ated with acute myocarditis as well as the presence of
inflammatory infiltrates in the DCM patients. This is a
likely reason that the adenoviruses have been overlooked as
significant causes of myocarditis over the years.
The question of whether adenoviruses are indeed a cause
of myocarditis in children and adults is further supported by
the recent finding of the so-called common Coxsackievirus
B-adenovirus receptor (30–32). This receptor binds both
group B Coxsackieviruses and the group C adenoviruses,
which are reported here and elsewhere to be the most
common viruses found in patients with myocarditis or
DCM. The discovery of this receptor lends further credence
to the idea that adenoviruses not only play a significant role
in the etiology of myocarditis and DCM but could also be
responsible for the occasional cases of “familial” myocarditis
where several family members develop DCM with clinical
data suggestive of myocarditis (33). Recently, Noutsias et al.
(34) reported the increased expression of Coxsackievirus
B-adenovirus receptor in the myocardium of patients with
DCM by comparison with normal hearts. Additionally,
Badorff et al. (35) reported the identification of Coxsack-
ievirus B3-encoded protease 2A-mediated degradation of
dystrophin in the hearts of infected mice leading to disrup-
tion of the dystrophin-associated glycoprotein complex.
These data support the role of viruses in the development of
DCM and suggest a commonality of pathogenesis between
the acquired and inherited forms of this disease because
mutations in dystrophin, as well as other proteins of the
cytoarchitecture, have been shown to cause DCM in hu-
mans and animals (36).
The data presented herein could have significant thera-
peutic consequences. Currently, few pharmacologic agents
have been developed for specific viral infections. Although
such agents as ribavirin, gancyclovir, and acyclovir have had
moderate impact on certain infectious disorders such as
RSV pneumonitis and CMV disease in transplanted pa-
tients, other therapeutic agents have been slow to develop.
Currently no specific therapy is approved for adenovirus or
enteroviruses. However, other approaches may be worth
considering. We have previously shown that EFE, a major
cause of DCM in the young that essentially disappeared by
the early 1980s, was caused by mumps virus (29). Based on
the chronology of the disappearance of the disease (i.e.,
beginning of mumps viral vaccination in the years just
before the extinction of EFE), it is likely that vaccination
was responsible for the impressive decrease in the reported
cases of EFE. Specific vaccinations for adenoviruses and
enteroviruses could result in diminished numbers of myo-
carditis and DCM cases, leading to drastic cuts in the
number of cardiac transplants and cost of care.
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